Shenji Changhua
神济昌华
Shenji Changhua
Biotech/Healthcare
Shenji Changhua is a biotechnology company focused on neurological diseases including amyotrophic lateral sclerosis (ALS). It develops innovative gene therapy technologies and drugs for patients with central nervous system diseases worldwide.
Latest round: Pre Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.